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Abstract: The vetiver essential oil from Chrysopogon zizanioides contains fragrant sesquiterpenes
used widely in the formulation of nearly 20% of men’s cosmetics. The growing demand and
issues in the supply have raised interest in the microbial production of the sesquiterpene khusimol,
the main compound of the vetiver essential oil due to its woody smell. In this study, we engineered
the biosynthetic pathway for the production of (+)-zizaene, the immediate precursor of khusimol.
A systematic approach of metabolic engineering in Escherichia coli was applied to modulate the
critical bottlenecks of the metabolic flux towards (+)-zizaene. Initially, production of (+)-zizaene
was possible with the endogenous methylerythritol phosphate pathway and the codon-optimized
zizaene synthase (ZS). Raising the precursor E,E-farnesyl diphosphate supply through the mevalonate
pathway improved the (+)-zizaene titers 2.7-fold, although a limitation of the ZS supply was
observed. To increase the ZS supply, distinct promoters were tested for the expression of the ZS gene,
which augmented 7.2-fold in the (+)-zizaene titers. Final metabolic enhancement for the ZS supply by
using a multi-plasmid strain harboring multiple copies of the ZS gene improved the (+)-zizaene titers
1.3-fold. The optimization of the fermentation conditions increased the (+)-zizaene titers 2.2-fold,
achieving the highest (+)-zizaene titer of 25.09 mg L−1. This study provides an alternative strategy to
enhance the terpene synthase supply for the engineering of isoprenoids. Moreover, it demonstrates
the development of a novel microbial platform for the sustainable production of fragrant molecules
for the cosmetic industry.
Keywords: khusimene; (+)-zizaene; vetiver essential oil; khusimol; sesquiterpenes; microbial
production; metabolic engineering
1. Introduction
The cosmetic industry has extensively used essential oils for the formulation of perfumes due to
their complex mixture of fragrant hydrocarbons such as ketones, ethers, esters, alcohols, aldehydes,
and terpenoids [1]. From these natural products, terpenes such as volatile monoterpenes, sesquiterpenes,
and diterpenes are the main constituents, which confer the specific odor to each essential oil [2].
Among the distinct essential oils, the vetiver essential oil (VEO) from the Ch. zizanioides
grass has drawn growing attention, because it is used in nearly 20% of men’s luxury perfumes [3].
Characterized by its dark woody smell, VEO holds a world production of 300–350 tons per year [4]
with prices ranging from $380–$500 per kg in 2018 [5] and expected growth in the market of $169.5
million for 2022 [6]. Industrial production of VEO is performed traditionally by steam distillation from
vetiver roots, harvested after 12–18 months of growth and at 1–2 m length; usually, this process attains
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an extraction yield of 0.2–3% and can be improved to 4% through supercritical fluid extraction [3,7].
The recurrent shortages in the supply of VEO from the main producer, Haiti due to rainfalls and
earthquakes [3,5], and the increasing market demand has raised the interest towards a reliable
biotechnological production of the main constituent of VEO, the sesquiterpene khusimol, which grants
the distinctive woody smell.
Similar to most plant sesquiterpenes, the biosynthesis of khusimol initiates from the glycolysis
cycle, which generates the precursors’ glyceraldehyde 3-phosphate (GAP) and pyruvate for the
plastidial methylerythritol phosphate (MEP) pathway, and acetyl coenzyme A (Acetyl-CoA) for the
cytoplasmic mevalonate (MEV) pathway [8]. Both pathways converge and catalyze the formation of
the terpene precursors isopentenyl pyrophosphate (IPP) and isomer dimethylallyl pyrophosphate
(DMAPP), which are further assembled by the farnesyl diphosphate synthase (IspA) to form the universal
sesquiterpene substrate E,E-farnesyl diphosphate (FDP) [9]. In the (+)-zizaene (syn. khusimene)
pathway, FDP is cyclized by the zizaene synthase (ZS) to yield (+)-zizaene and further hydroxylated to
khusimol by a specific P450 cytochrome monooxygenase [10].
The biosynthetic pathway of khusimol should be possible in E. coli because of the positive results
for the in vivo production of many sesquiterpenes [11]. Contrary to plants, E. coli produces endogenous
FDP exclusively by the MEP pathway and is vital for the biosynthesis of the intermediates undecaprenyl
diphosphate (UDP) and octaprenyl diphosphate (ODP) [12]. Accordingly, UDP is the direct precursor
of peptidoglycans, used for cell wall formation [13], and ODP is involved in the respiratory chain for
the biosynthesis of distinct quinones [14]. Consequently, amounts of FDP in E. coli are limited; thus,
efforts have been made to engineer the MEP pathway to enhance the supply of FDP. As an example,
the overexpression of the MEP pathway genes 1-Deoxy-D-xylulose 5-phosphate synthase (DXS) and
1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR) increased the FDP levels and improved
the amounts of lycopene up to 22 mg L−1 [15]. Similarly, overexpression of the DXS synthase and
additionally, the isoprenyl diphosphate isomerase (Idi) with the farnesyl pyrophosphate synthase
(FPS) reached valerenadiene titers of 2.09 mg L−1 [12]. Although overexpression of the MEP pathway
improved the precursor supply, the terpene titers did not reach industrial levels, possibly due to control
mechanisms of E. coli or the formation of intermediates that limited the precursor supply [16,17].
As an alternative to raise the FDP supply, the heterologous MEV pathway was engineered in E. coli
by Keasling and co-workers for the in vivo production of amorpha-4,11-diene [17]. The heterologous
pathway involved the cloning of eight genes from E. coli and Saccharomyces cerevisiae into two operons:
MevT operon converted acetyl-CoA to mevalonate and MBIS operon catalyzed mevalonate to IPP and
DMAPP that led to FDP, yielding 112.2 mg L−1 as the highest amorpha-4,11-diene titer. The microbial
platform was further enhanced for the production of bisabolene by optimizing the codon usage to
E. coli for the S. cerevisiae genes and assembling the eight genes into one single operon under the control
of the lacUV5 (MevT genes) and trc promoter (MBIS genes) [18]. As a result, the upgraded platform
boosted the FDP supply and achieved titers of 900 mg L−1 of bisabolene.
The previously mentioned studies augmented the supply of the substrate FDP, which is further
catalyzed in the terpene pathway by a terpene synthase (TPS), performing complex reactions that
yield sesquiterpenes with precise structure and stereochemistry [19]. In the biosynthesis of khusimol,
the TPS is the ZS that catalyzes the cyclization of FDP to the tricyclic (+)-zizaene. Its enzymatic
characterization has been described by a recombinant codon-optimized variant fused to the small
ubiquitin-related modifier (SUMO), which increased the solubility of ZS and expressed heterologously
in E. coli [10]. Moreover, the catalytical specificity and enzymatic kinetics of the ZS enzyme have been
further characterized [20].
In this study, we report the metabolic engineering of (+)-zizaene biosynthesis in E. coli strains.
The engineering of the biosynthetic pathway involved the overexpression of the MEV pathway to
enhance the FDP supply, the evaluation of promoters to efficiently express the ZS, and the engineering
of multi-plasmid strains with multiple copies of ZS to boost the ZS supply. Moreover, optimization of
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the fermentation conditions and evaluation of E. coli strains were analyzed to improve the production
of (+)-zizaene.
2. Materials and Methods
2.1. Engineering of Vectors and Strains
The description of vectors and strains is summarized in Table 2. The pETSUMO::ZIZ(co) vector
was obtained from our previous study [10], and the sequence of the codon-optimized SUMO-fused
ZS gene was described in GenBank accession KP231534. The vector pBbA5c-MevT(CO)-MBIS (CO,
ispA), encoding the MEV pathway, was a gift from Jay Keasling & Taek Soon Lee (Addgene plasmid
#35151). The pJbei-6411 vector for the expression with the arabinose operon was a gift from Taek Soon
Lee (Addgene plasmid #47050).
The cloning procedures were carried out by the NEBuilder HiFi DNA Assembly method,
and PCR reactions were performed with the Q5 HiFi DNA polymerase, both following the provider
protocols (New England BioLabs, USA). Synthesis of oligonucleotides and sanger sequencing for clone
confirmation were performed by Microsynth Seqlab (Germany), and primer sequences are described
in Table 1.
Table 1. Primers used in this investigation.
Primers Description Reference
ZS-F-Mev catccagcgtaataaataagGATCTAGGAGGTAATGGGCAGCAGCCATCATC This study
ZS-R-Mev gagatccttactcgagtttgTCACACCGGAATCAGATTTACATAC This study
pJ6411-F-ZS cccaagattacgtacattg This study
pJ6411-R-ZS ttctttatcctcctagatcttttgaattcccaaaaaaacg This study
ZS-F-pJ6411 ccgtttttttgggaattcaaaagatctaggaggataaagaaATGGGCAGCAGCCATCATC This study
ZS-R-pJ6411 tcaatgtacgtaatcttgggTCACACCGGAATCAGATTTACATAC This study
Upper case sequences: Inserts. Lower case sequences: backbone vector. Upper case underlined sequences: IRES
For the production of (+)-zizaene by a single polycistronic vector, the ZS gene was cloned into the
pMev vector, directly after the IspA gene to yield the pMevZS vector. In brief, the ZS gene was amplified
from the pETZS vector by respective primers with complementary overhangs to the BamHI site of
the pMev vector. Additionally, an internal ribosome entry site (IRES) (GATCTAGGAGGTA) from the
MEV operon was cloned upstream from the ZS gene. Thereafter, the pMev vector was digested with
BamHI, assembled with the ZS gene and E. coli NEB 10-beta competent cloning strain (New England
BioLabs), which is specific for large vectors, was transformed with the pMev vector. For the testing of
the PBAD promoter through the pJbeiZS plasmid, the cytochrome P450 operon from pJbei-6411 vector
was removed, and the ZS gene from the pETZS vector was inserted instead. For that, both the insert
and backbone were amplified with complementary overhangs by PCR methods, seamlessly assembled,
and E. coli TOP10 competent cloning strains (IBA, Germany) were transformed for respective screening.
For the production of (+)-zizaene, E. coli expression strains were transformed or co-transformed
with the respective plasmids by common methods [21]. An exception was the BZS+Mev strain,
where the E. coli TOP10 competent cloning strain was used because expression with the arabinose
operon requires a non-metabolizing arabinose strain [22].
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Table 2. Strains and plasmids used in this investigation.
Plasmid Reference Plasmid Name
Description (Origin of Replication,
Promoter, Antibiotic Resistance
and Genes)
Reference
pETZS pETSUMO::ZIZ(co)
pBR322, PT7, Kan, harboring the
codon-optimized SUMO-fused ZS gene
from Ch. zizanioides
[10]
pMev pBbA5c-MevT(CO)-MBIS (CO, ispA)
p15A, PlacUV5, Cam, harboring the
mevalonate pathway genes: AtoB, HMGS,
tHMGR, MK, PMK, PMD, Idi and IspA*.
[18]
pJbei-6411 pJbei-6411
pBBR1, PBAD, Kan, harboring the arabinose
operon with the cytochrome P450
(CYP153A6) from Sphingomonas sp.
[23]
pMevZS pBbA5c-MevT(CO)-MBIS (CO,ispA)-SUMO::ZIZ(co)
p15A, PlacUV5, Cam, harboring the
mevalonate pathway genes* and the
codon-optimized SUMO-fused ZS gene
from Ch. zizanioides
This study
pJbeiZS pJbei-6411-SUMO::ZIZ(co)
pBBR1, PBAD, Kan, harboring the arabinose
operon and the codon-optimized
SUMO-fused ZS gene from Ch. zizanioides
This study
Strains Genotype/Description Reference
E. coli TOP10 F
- mcrA (mrr-hsdRMS-mcrBC) φ80lacZ ∆M15 ∆lacX74 recA1 ara∆139 (ara-leu)7697 galU
galK rpsL (StrR) endA1 nupG IBA
E. coli Bl21(DE3) F- ompT hsdSB (rB-mB-) gal dcm (DE3) Novagen
E. coli Tuner(DE3) F- ompT hsdSB (rB-mB-) gal dcm lacY1(DE3) Novagen
E. coli NEB 10-beta ∆(ara-leu) 7697 araD139 fhuA ∆lacX74 galK16 galE15 e14- φ80dlacZ∆M15 recA1 relA1endA1 nupG rpsL (StrR) rph spoT1 ∆(mrr-hsdRMS-mcrBC) NEB
E. coli SHuﬄe T7
fhuA2 lacZ::T7 gene1 (lon) ompT ahpC gal λatt::pNEB3-r1-cDsbC (SpecR, lacIq) ∆trxB
sulA11 R(mcr-73::miniTn10–TetS)2 (dcm) R(zgb-210::Tn10 –TetS) endA1 ∆gor
∆(mcrC-mrr)114::IS10
NEB
E. coli SHuﬄe T7 lysY
MiniF lysY (CamR)/fhuA2 lacZ::T7 gene1 (lon) ompT ahpC gal λatt::pNEB3-r1-cDsbC
(SpecR, lacIq) ∆trxB sulA11 R(mcr-73::miniTn10–TetS)2 (dcm) R(zgb-210::Tn10 –TetS)
endA1 ∆gor ∆(mcrC-mrr)114::IS10
NEB
Mev E. coli Bl21(DE3) harboring pMev This study
ZS E. coli Bl21(DE3) harboring pETZS This study
MevZS E. coli Bl21(DE3) harboring pMevZS This study
BZS+Mev E. coli TOP10 harboring pMev and pJbeiZS This study
TZS+Mev E. coli Bl21(DE3) harboring pMev and pETZS This study
TZS+MevZS E. coli Bl21(DE3) harboring pMevZS and pETZS This study
T-TZS+MevZS E. coli Tuner(DE3) harboring pMevZS and pETZS This study
SH-TZS+MevZS E. coli SHuﬄe T7 harboring pMevZS and pETZS This study
SHL-TZS+MevZS E. coli SHuﬄe T7 lysY harboring pMevZS and pETZS This study
Kan, kanamycin and Cam, chloramphenicol.
2.2. Evaluation of the Engineered Strains for the Production (+)-zizaene
Cultivations of E. coli were performed by inoculating 100 µL of respective strains from glycerol
stocks to 10 mL Lysogeny Broth (LB) pre-culture broths at 37 ◦C with respective antibiotics (kanamycin
at 30 µg L−1 and, or chloramphenicol at 34 µg L−1) until the stationary phase. Furthermore, production
cultures in sealed baﬄed shake-flasks with 35 mL of defined non-inducing broth (DNB) [24] were
inoculated with 2% (v/v) of seed culture and grown at 37 ◦C on a rotatory shaker (150 rpm). After cultures
reached a cell density of OD600 0.6, (+)-zizaene production was induced by adding varying levels
(0.1, 0.5, and 1.0 mM) of isopropyl-β-D-1-thiogalactopyranoside (IPTG) and an overlay of 4 mL
iso-octane at 20 ◦C, (150 rpm) as a two-phase partitioning culture. After 24 h of induction, samples
were taken promptly for analytical measurements that included dried cell weight (DCW), cell density,
soluble ZS protein, and (+)-zizaene concentrations.
2.3. Optimization of the Fermentation Conditions for the Production (+)-zizaene
Cultivation and analytical procedures for media evaluation, optimization of growth temperature
and media pH, and testing of E. coli strains were carried out as described before with the best
performing strain. The evaluation of media comprised the defined media: defined non-inducing broth
(DNB), M9 minimal medium (M9) [25], and a modified Aparicio defined medium (ADM) with the
following composition (g L−1): (NH4)2SO4 10.0, NaCl 1.2, K2SO4 1.1, MgSO4·7H2O 0.15, K2HPO4
9.3, KH2PO4 2.03, CaCl2 0.01, FeSO4·7H2O 0.001, and CuSO4·5H2O 0.001 [26]. Defined media were
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set to pH 7.2 and 5 g L−1 of glucose respectively. Additionally, the complex terrific broth (TB) [21]
was used as a control. The factorial design for the pH and temperature optimization consisted of
two factors with the following levels: pH (6.5, 7, and 7.5) and temperature (16, 20, 24, and 28 ◦C),
for a total of 12 combinations with three replicates. Data were analyzed and plotted using the Minitab
16 software (USA).
2.4. Analytical Measurements
2.4.1. ZS Protein Gel Electrophoresis Analysis
Production culture samples were normalized to an OD600 2, centrifuged for 10 min (10,000× g
at 4 ◦C) and free-media pellet was resuspended in 300 µL extraction buffer (50 mM MOPS, 150 mM
NaCl, 5 mM DTT, 10% (v/v) glycerol, pH 7.5). Cells were disrupted through an ultrasonicator
(Sartorius Labsonic, Goettingen, Germany) and soluble and insoluble protein fractions were separated
after 30 min centrifugation (10,000× g at 4 ◦C). Protein fraction samples were mixed with 2X loading
buffer, heated at 95 ◦C for 5 min and analyzed through a 10% sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE).
2.4.2. Identification and Measurement of (+)-zizaene by Gas Chromatography Analysis
Samples of 150 µL from the iso-octane overlay from production cultures were transferred to
GC-vials for gas chromatography analysis and product identification was carried out through GC-MS
using an Agilent 7890B system (Agilent, Santa Clara, CA, USA) with the following settings: sample
injections of 0.5 µL on-column mode through a 30 m VF-WAXms capillary column (0.25 mm internal
diameter I.D. × 0.25 µm, Agilent, USA); oven program of 40 ◦C for 3 min, increasing to 230 ◦C (10 ◦C
min−1) and final hold of 10 min; helium 5.0 carrier gas at a constant gas flow of 1 mL min−1; temperature
of 230 ◦C for ion source, and 150 ◦C for quadrupole; mass scan range of 33–300 m/z and ionization
energy to 70 eV. Terpene products were identified by comparison of retention indices [27] and mass
spectra of samples with authentic standards from the VEO and references from the mass spectral NIST
14 database.
Quantification of (+)-zizaene was performed by GC-FID with a GC-2010 plus GC system coupled
to a flame ionization detector (Shimadzu, Japan) equipped with a 30 m Zebron ZB-Wax Plus column
(0.25 mm I.D. × 0.25 µm, Phenomenex, USA). Samples of 1 µL were injected under a splitless mode
with an injector temperature of 240 ◦C. The initial oven temperature was set to 40 ◦C for 20 s, ramped at
10 ◦C min−1 to 200 ◦C, held for 0.5 min, increased at a rate of 30 ◦C min−1 to 230 ◦C, and held finally
for 2 min. Because the (+)-zizaene standard is not commercially available, an α-cedrene standard was
used as an equivalent standard due to the relative abundance of the main peaks from the mass spectra
as described in our previous report [20].
3. Results
3.1. Engineering the Production of (+)-zizaene by the MEP Pathway
In this study, we engineered the biosynthetic pathway in E. coli for the production of (+)-zizaene,
using glucose as the sole carbon source (Figure 1). The key enzyme of the biosynthesis of (+)-zizaene
is the ZS, which catalyzes the cyclization of the substrate FDP to (+)-zizaene. Due to the plant
origin of TPS, most are expressed poorly in E. coli, leading to the formation of insoluble proteins
(inclusion bodies) [28,29]. To improve TPS solubility, a recombinant ZS variant was used, which was
codon-optimized for E. coli and fused with the SUMO moiety from our previous work [30].
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Figure 1. Biosynthetic pathway engineered for the production of (+)-zizaene in E. coli by the expression
of the native methylerythritol phosphate (MEP) pathway, the heterologous MEV pathway and the
(+)-zizaene pathway. Heterologous expressed enzymes highlighted in blue. The MEP pathway
comprise the following enzymes: 1-Deoxy-D-xylulose 5-phosphate synthase (Dxs), 1-deoxy-D-xylulose
5-phosphate reductoisomerase (Dxr), MEP cytidyl transferase (MCT), cytidyl MEP kinase (CMK),
MEP-2,4-cyclodiphosphate synthase (MDS), (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase
(HDS), and (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase (HDR). The MEV heterologous
pathway consisted of the following enzymes: acetyl-CoA acetyltransferase (AtoB), HMG-CoA synthase
(HMGS), truncated HMG-CoA reductase (tHMGR), mevalonate kinase (MK), phosphomevalonate
kinase (PMK), mevalonate diphosphate decarboxylase (PMD), and isoprenyl diphosphate isomerase
(Idi). The (+)-zizaene pathway comprises the farnesyl diphosphate synthase (IspA) and the zizaene
synthase (ZS).
For the overexpression of (+)-zizaene, the production cultures were performed by the two-phase
partitioning method [31] with a DNB medium and an overlay of iso-octane, which reduces the loss of
(+)-zizaene due to its volatility. After 24 h of culture, organic phases from production cultures were
obtained and analyzed through GC-MS for the identification of terpenes. All tested strains produced
(+)-zizaene as the main product (90%) and β-acoradiene as a side product (10%) (Figure 2), except for
the Mev strain (negative control) because it lacks the ZS gene and harbors the MEV pathway (Figure 3a).
Additionally, the Mev strain produced farnesol, which is a product from the hydroxylation of FDP by
endogenous phosphatases from E. coli [32].
Figure 2. Identification of terpene products by GC–MS. (A) Total ion chromatogram. (B) Chemical
structures of the identified products. (C) Mass spectra of (+)-zizaene from the sample of the ZS+MevZS
strain. (D) Mass spectra of (+)-zizaene authentic standard from the vetiver essential oil. Comparison of
mass spectra for β-acoradiene is shown in the Supplementary Table S1.
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Figure 3. Comparison of the performance of the engineered E. coli BL21(DE3) strains induced at
different IPTG levels. (A) (+)-zizaene titers. (B) (+)-zizaene yields. (C) biomass from cell dry weight
(D) cell density. Data are the mean of four independent replicates from production cultures after 24 h
of induction with DNB medium, and the error bars represent the standard deviation. * BZS+Mev E. coli
Top10 strain induced with 1 mM IPTG and different levels of arabinose (Ara).
As a first attempt to produce (+)-zizaene, the TZS strain was constructed with the ZS gene under
the control of the T7 promoter and the FDP supply originated from the endogenous MEP pathway
from E. coli BL21(DE3) strain. As shown in Figure 3a, the (+)-zizaene titer of the TZS strain was the
lowest when compared to all the tested strains; however, it achieved the highest cell growth (biomass
2.9 g L−1 and cell density of OD600 7.2, Figure 3c,d) and amounts of soluble ZS protein (Figure 4b) for
the TZS strain induced at 0.1 mM IPTG. These observations suggest a low metabolic burden due to
the overexpression of a single recombinant protein (ZS). Moreover, it evidences the limited supply of
the endogenous FDP from E. coli, which is required for the biosynthesis of isoprenoid quinones and
peptidoglycans [13,14].
Figure 4. Evaluation of the overexpression of the soluble (SF) and insoluble (IF) ZS protein fractions
from the engineered E. coli BL21(DE3) strains, induced at different IPTG levels by 10% SDS-PAGE. (M)
molecular marker. * BZS+Mev induced with 1 mM IPTG and different levels of arabinose (Ara).
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3.2. Improving the Titers of (+)-zizaene through the Mevalonate Pathway
To raise the supply of the precursor FDP, the polycistronic pMevZS vector was constructed with
the ZS gene and the exogenous MEV pathway (Figure S1), which was obtained from the pMEV vector
that harbors the following genes: AtoB, HMGS*, tHMGR*, MK*, PMK*, PMD, IDI, and IspA (*genes from
S. cerevisiae that were codon-optimized to E. coli) [18]. Consequently, a single mRNA transcript was
expressed under the control of the lacUV5 promoter. As a result, overexpression of the heterologous
MEV pathway with the ZS gene (MevZS strain) induced with 0.1 mM IPTG augmented the (+)-zizaene
production and yield by 2.7 and 5-fold respectively when compared to the TZS strain (Figure 3a,b).
Thus, a relation was observed in both TZS and MevZS strains, where higher amounts of IPTG increased
the overexpression of insoluble ZS protein (Figure 4a,c). Moreover, overexpression of the MEV pathway
generated a strong metabolic burden, where cell growth diminished by 1.8-fold biomass and 2.1-fold
cell density when compared to that of the strain lacking the MEV pathway (TZS strain) (Figure 3c,d).
Although the overexpression of the MEV pathway raised the FDP supply, the production of soluble ZS
protein declined dramatically when compared to the TZS strain (Figure 4c), suggesting that the ZS
supply became the limiting factor.
3.3. Effect of Promoters on the Overexpression of the ZS Gene
The low ZS supply demonstrated by the MevZS strain could result from either expression
mechanisms of polycistronic vectors and, or by the promoter strength. To prove these hypotheses,
multi-vector strains were constructed harboring the following plasmids: polycistronic pMev vector
(MEV pathway) and monocistronic ZS vector ((+)-zizaene pathway). Two versions of the ZS vectors
were constructed in order to test the effect of promoters on the ZS supply. The designed ZS vectors
comprised the pETZS vector with the strong T7 promoter and the pJbeiZS vector harboring the weak
PBAD promoter (Figure S2). The overexpression of the ZS gene under the control of the PBAD promoter
(BZS+Mev strain) did not enhance the (+)-zizaene titers when compared to the MevZS strain, but it did
increase the (+)-zizaene yield by 2.5-fold when induced with 50 mM arabinose (Figure 3b). Nevertheless,
the BZS+Mev strain showed the lowest cell growth of all the tested strains (biomass 0.63 g L−1 and
cell density of OD600 1.0, Figure 3c,d). Furthermore, overexpression of the ZS gene controlled by the
T7 promoter (TZS+Mev strain) raised the amounts of soluble ZS protein when compared to that of
the induced with the PBAD promoter (Figure 4d,e). As a consequence, the (+)-zizaene production and
yield augmented 7.2 and 4.4-fold, respectively when compared to the BZS+Mev strain, and 7.2 and
11.3-fold correspondingly when compared to the MevZS strain (Figure 3a,b). Such strategy improved
the ZS supply and consequently restored the flux balance of the (+)-zizaene biosynthesis.
3.4. Enhancing the ZS Supply by Engineering Multiple Copies of the ZS Gene
Overexpression of the ZS gene with the T7 promoter seemed to overcome the ZS supply limitations
of the MevZS and BZS+Mev strains. Nevertheless, the optimal amount of ZS to catalyze the FDP
supply still remains unknown. To increase the ZS supply even further, a multi-vector strain that
harbored two copies of the ZS gene was engineered. For that, the TZS+MevZS strain was developed,
harboring the pETZS and pMevZS vectors, and controlling the expression of the ZS genes by the T7
and lacUV5 promoters. As a result, the multi-copy ZS gene strain achieved the best results of all the
constructed strains (titer: 13.7 mg L−1 and yield 11.6 mg g−1 DCW) and raised 1.3-fold the (+)-zizaene
titers and 1.6-fold the yields in comparison to the TZS+Mev strain (one ZS gene copy) (Figure 3a,b).
Moreover, it augmented the (+)-zizaene production and titer by 9.7 and 18.4-fold correspondingly
when compared to the single-vector MevZS strain. These results suggest that the bottleneck of the
metabolic flux was still the ZS supply, which could be improved by the combination of the T7 promoter
with multiple copies of the ZS gene, harbored on a multi-vector strain.
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3.5. Optimization of Fermentation Conditions and Evaluation of E. coli Strains
To raise further the production of (+)-zizaene, fermentation tests were carried out at shake flask
scale, comprising the evaluation of culture media, optimization of growth temperature and media
pH, and testing of E. coli strains. Accordingly, the mineral-salt defined media DNB, ADM, and M9
were tested due to their previous use in metabolic engineering studies and suitability to control
carbon-limited growth required for fed-batch or continuous cultivations to reach high-cell density
cultures [33]. To compare the performance of defined media against complex media, the TB broth was
used. As a result, substantial differences were observed between the defined media, where the highest
(+)-zizaene levels and yields were obtained by ADM media, followed by DNB and M9 media (Figure 5a).
Consequently, the ADM medium was 1.8-fold higher than the DNB medium for the (+)-zizaene titers
and 1.2-fold higher for the (+)-zizaene yields. Both tested media were of similar formulation with the
exception of the trace elements and nitrogen composition, whereas the concentration of nitrogen of the
ADM medium was 2.5-fold higher than the DNB medium. Likewise, cell growth followed a similar
behavior to that of the (+)-zizaene production among the tested media, where the complex TB broth
had the highest cell growth when compared to the defined media tests (Figure 5b). However, the ADM
medium obtained the highest (+)-zizaene yields (16.2 mg g DCW−1) when compared to all the tests
and was consequently selected for further tests.
Figure 5. Optimization of the fermentation conditions and testing of E. coli strains for the improvement
of the terpene performance. Evaluation of production media: (A) (+)-zizaene titers and yields,
(B) biomass and cell density. Optimization of growth temperature and media pH: (C) (+)-zizaene titers,
(D) (+)-zizaene yields. Evaluation of E. coli strains: (E) (+)-zizaene titers and yields, (F) biomass and
cell density. Data are the mean of four independent replicates from production cultures after 24 h of
induction, and the error bars represent the standard deviation.
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To further improve the fermentation conditions, factorial designs of two levels were implemented
for the optimization of growth temperature and pH of the ADM medium. Accordingly, optimal
(+)-zizaene levels were found between 19.5-21.8 ◦C and pH 6.8-7.08 (Figure 5c) and for (+)-zizaene yields
between 18-20.8 ◦C and pH 6.8-7.1 (Figure 5d). Temperature affected (+)-zizaene levels differently than
yields, whereas moderate (+)-zizaene levels (15-21 mg L−1) were shown at a broad range of temperature
(17.5-27.7 ◦C). On the contrary, pH had nearly the same effect on both variables. Additionally, the highest
levels of soluble ZS protein were found at lower pH and temperatures (Figure 6b). Tests at pH 6.5
also produced the highest amounts of insoluble ZS protein, resulting in the lowest (+)-zizaene levels.
Similarly, tests carried out at 16 ◦C dropped the (+)-zizaene levels despite the high amounts of soluble
ZS protein, possibly due to enzymatic mechanisms. As a result, the optimal fermentation conditions
were determined as 20 ◦C and pH 7.0, which improved the (+)-zizaene levels to 21.5 mg L−1 and yields
to 16.2 mg g−1 DCW.
Figure 6. Analysis of the over-expression of soluble (SF) and insoluble (IF) ZS protein fractions from
the optimization of fermentation conditions and testing of E. coli strains by 10% SDS-PAGE. (A) Culture
media test. (B) Temperature and pH optimization. (C) E. coli strains test. (M) molecular marker.
Strain tests were carried out under optimal fermentation conditions (ADM medium, 20◦ C and pH
7) to assess the features of the E. coli B strains SHuﬄe T7, SHuﬄe T7 lysY, Tuner(DE3) and BL21(DE3),
and measure their impact on the production of (+)-zizaene. The SHuﬄe-based strains were selected
to test if there could be an enhancement in the folding of ZS due to the effect of a disulfide bond
chaperone DsbC. Additionally, the SHuﬄe T7 lysY variant reduces the basal expression for toxic
genes through the expression of lysozyme, coded by the lysY gene. Similarly, the BL21(DE3) variant,
the Tuner(DE3) strain lacks the lacY gene that codes for the β-galactosidase permease, which allows
fine-tuning for induction and reduces basal expression. As a control, the BL21(DE3) strain was used.
As presented in Figure 5e, the differences between the BL21-based and SHuﬄe-based strains were
remarkable; unexpectedly, the best results were shown by the Tuner(DE3) strain, followed by the
BL21(DE3), SHuﬄe T7, and SHuﬄe T7 lysY strains. These observations demonstrate that the strains
expressing the lowest number of recombinant proteins produced the highest cell growth (Figure 5f),
and soluble ZS protein amounts (Figure 6c), and consequently, the highest (+)-zizaene titers and
yields (shown by increasing number of recombinant proteins: Tuner(DE3): ZS; BL21(DE3): ZS, lacY;
SHuﬄe T7: ZS, lacY, DsbC; SHuﬄe T7 lysY: ZS, lacY, DsbC, lysY). Overexpression of the chaperones by
the SHuﬄe-based strains did not have the expected results; instead, it showed deleterious effects as
observed from the low amounts of ZS protein. As a result, the strain that expressed the minimum
number of recombinant proteins, the Tuner(DE3) strain, enhanced 1.2-fold the (+)-zizaene levels and
1.4-fold the yields in comparison with the control BL21(DE3) strain.
Finally, the applied approach for the optimization of the fermentation conditions improved the
(+)-zizaene titers 2.2-fold and yields 1.7-fold when compared to the strains without optimization
Genes 2019, 10, 478 11 of 15
(Section 3.4), achieving the highest (+)-zizaene production of 25.09 mg L−1 and yield 23.33 mg g−1
DCW for this study.
4. Discussion
The production of (+)-zizaene was metabolically engineered in E. coli by a recombinant
codon-optimized SUMO-fused ZS that enhanced the amounts of soluble ZS protein [10].
Moreover, the optimization of the metabolic flux to (+)-zizaene was the greatest challenge, where the
FDP and ZS supply were identified as the limiting factors. Consequently, a strategy was applied to
gradually increase the supply of both and augment the metabolic rate driving force towards (+)-zizaene.
Initially, production of (+)-zizaene was possible by using the endogenous MEP pathway from
E. coli (TZS strain) but at a lower extent. The high amounts of soluble ZS protein and low titers of
(+)-zizaene suggest a limitation on the FDP supply. For that reason, the exogenous MEV pathway was
applied, which is the ubiquitous pathway in plants for the biosynthesis of the sesquiterpene substrate
FDP [34]. Hence, the pMevZS vector was constructed as a polycistronic vector, including all the required
genes for terpene production into one vector. Such a strategy has been used for the engineering of many
terpenes [23,28,35] because the maintenance of a single vector by the host cells is more efficient than
for multi-vectors [36]. As a result, the overexpression of the MevZS strain did not increase the levels of
(+)-zizaene as expected; possibly due to the lower amounts of soluble ZS protein than the TZS strain.
This could be explained by the moderate strength of the lacUV5 promoter [37], theimproved variant
of the lac promoter from E. coli [38]. Additionally, the ZS gene was placed eight genes downstream
from the promoter in the polycistronic pMevZS vector and eventually, this gene order could affect the
overexpression of ZS, as demonstrated by other studies [39–41]. Moreover, the overexpression of the
nine genes produced a large mRNA transcript, which is usually more unstable as short transcripts [42].
Thus, the increase in the FDP supply and the decline in the soluble ZS protein amounts suggest that
the limiting factor shifted to the ZS supply. This scenario was deleterious for an optimal metabolic rate,
because ZS suffers substrate inhibition from FDP at higher levels of 5 µM, as shown in our previous
report [20].
To raise the ZS supply, the monocistronic vectors pJbeiZS and pETZS were designed by cloning
the ZS gene directly after the promoter and further co-transformed into the strain with the pMev vector.
The use of the BZS+Mev strain was initially promising because it is capable of tuning the metabolic flux,
using unique inducers for FDP (IPTG) and ZS (Arabinose). However, results with the PBAD promoter
were similar to those obtained by the MevZS strain, possibly due to the similarity in the strength of the
PBAD promoter versus the lacUV5 promoter [37]. Similar outcomes were demonstrated by others, where
the lacUV5 and PBAD promoters produced low or even undetectable levels of sesquiterpenes [11,12].
Additionally, accumulation of toxic intermediates due to a higher metabolic burden could occur because
the BZS+Mev strain harbors the high-copy pJbeiZS plasmid with the pBBR1 origin of replication [43].
On the other hand, overexpression of soluble ZS protein with the T7-promoter (TZS+Mev strain) was
drastically higher than with the PBAD promoter (BZS+Mev strain) and subsequently, the production of
(+)-zizaene increased considerably.
We ventured to raise further the ZS supply by adding a second copy of the ZS gene through the
TZS+MevZS strain. As a result, the production of (+)-zizaene was the greatest of all the engineered
strains and suggests that the limiting factor was still the ZS supply. The improvement in (+)-zizaene
levels could be due to the effect of overexpressing the ZS genes by two different promoters on two
different vectors (T7 in pETZS and lacUV5 in pMevZS). Such strategy could have been a contributive
factor, possibly by overexpressing the ZS gene by different promoters, by RBS strength differences
from the used vectors, and by the vector copy numbers, which are unequal on multi-plasmid
strains due to differences between replication origins, antibiotic markers, and plasmid sizes [16,42].
However, more tests are required to draw such conclusions. Additionally, it seems that the in vivo
production of (+)-zizaene requires higher amounts of the TPS when compared to other sesquiterpenes
such as vetispiradiene (KM = 0.7µM for the vetispiradiene synthase) [44], due to the low enzyme activity
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of ZS (KM = 0.88 µM) [20]. Therefore, increasing the copy number of the TPS gene in a multi-vector
strain was a plausible strategy to improve the flux to (+)-zizaene.
Optimal fermentation conditions are crucial for efficient microbial growth and metabolization
of glucose flux towards terpenes, as demonstrated by many reports [11,45,46]. Regarding the media
evaluation, the ADM medium achieved the highest production of (+)-zizaene when compared to the
other defined media tests. The main difference in media formulation between tests was the higher
amount of nitrogen from the ADM medium, suggesting that nitrogen concentration was the most
relevant factor; particularly, because nitrogen is required for the biosynthesis of amino acids that
regulates the production of cellular and recombinant proteins [47]. This could explain the higher cell
growth and soluble ZS protein levels from the ADM medium tests when compared to the other tests,
which in turn improved the (+)-zizaene levels.
Optimization of the temperature and media pH can enhance the production of sesquiterpene as
observed with the microbial production of vetispiradiene, 5-epi-aristolechene and (+)-δ-cadinene [11].
For the production of (+)-zizaene, the optimal fermentation conditions were found at 20 ◦C and
pH 7.0, which differ from the optimal reaction conditions from the ZS in in vitro biotransformations
with FDP (36 ◦C, pH 7.5) [20]. Thus, the greatest difference between the experimental conditions
was the temperature, due to its relevant effect over protein synthesis rate, cell growth, and enzyme
activity [11,48]. Accordingly, tests cultivated at 16 ◦C and pH 6.5-7, overexpressed high amounts of
soluble ZS protein but the (+)-zizaene levels and cell growth were low. These results suggest that the
activity of the ZS was drastically reduced at 16 ◦C, due to its preference for higher temperatures (optimal
at 36 ◦C). On the other hand, temperatures higher than 20 ◦C resulted in higher amounts of insoluble
ZS protein than the soluble form. These observations confirm that an optimal temperature of 20 ◦C was
required to achieve a balance between cell growth and active ZS protein. Regarding the effect of the
media pH on (+)-zizaene production, the optimal pH was found to be neutral pH and values different
than that lowered the (+)-zizaene titers. Additionally, lower pH values promoted the formation of
insoluble ZS protein. Such behavior was observed before in uncontrolled-pH E. coli cultures grown in
shake flasks, whereas overexpression of fused SpA-βgal protein at pH < 5.5 augmented the inclusion
body formation, possibly due to regulatory mechanisms for pH homeostasis [49]. Therefore, tests grown
at pH 7 at 20 ◦C achieved the balance between insoluble and soluble ZS protein fractions that led to the
highest production of (+)-zizaene.
The evaluation of E. coli B strains revealed considerable differences in terpene production due to
the particular feature of each strain. The terpene performance increased with the strains that expressed
the lower number of recombinant proteins such as the BL21(DE3)-based strains. These results
suggest that the expression of the ZS protein is not affected by basal expression (lysY gene), neither
the β-galactoside permease is required (lacY gene), nor the chaperon DsbC enhanced the protein
folding and disulfide bond formation, although the ZS protein contains cysteines. On the contrary,
overexpression of DsbC drastically dropped the amounts of soluble ZS protein and the (+)-zizaene
titers. Consequently, the Tuner(DE3) strain achieved the best performance for terpene production
by overexpressing the minimum number of recombinant proteins, thus avoiding the production of
unnecessary proteins (β-galactoside permease, DsbC, and lysozyme). This strategy diminished the
metabolic burden, defined as the resources consumed for cell maintenance and recombinant protein
synthesis that is inversely proportional to cell growth [48]. This was confirmed by the higher biomass
amount from the Tuner(DE3) strain when compared to the other tested strains. As a result, the lower
metabolic burden from the Tuner(DE3) strain improved the efficiency of the carbon flux towards
(+)-zizaene.
5. Conclusions
In this work, we demonstrated the metabolic engineering ofE. coli strains for the in vivo production
of (+)-zizaene. Moreover, we optimized the limiting factors of the metabolic flux to (+)-zizaene by the
overexpression of the MEV pathway, and by boosting the ZS supply by increasing the number of copies
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of the ZS gene with T7 promoters on a multi-plasmid strain. Final improvement was achieved by
optimizing the fermentation conditions and testing of E. coli B strains to a final (+)-zizaene production
of 25.09 mg L−1 at the shake flask scale. This work offers new insights into the optimization of the
metabolic pathway and fermentation conditions for the in vivo production of sesquiterpenes and the
development of a novel microbial platform towards the industrialization of fragrant molecules.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4425/10/6/478/s1,
Figure S1: Confirmation of seamless cloning for pMevZS; Figure S2: Confirmation of seamless cloning for pJbeiZS;
Table S1: Mass spectra of the identified products.
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